Annual Total Long Term Liabilities
$26.80 B
-$2.57 B-8.75%
31 December 2023
Summary:
Novartis AG annual total long term liabilities is currently $26.80 billion, with the most recent change of -$2.57 billion (-8.75%) on 31 December 2023. During the last 3 years, it has fallen by -$11.25 billion (-29.56%). NVS annual total long term liabilities is now -29.56% below its all-time high of $38.05 billion, reached on 31 December 2020.NVS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$31.95 B
+$3.96 B+14.15%
30 September 2024
Summary:
Novartis AG quarterly total long term liabilities is currently $31.95 billion, with the most recent change of +$3.96 billion (+14.15%) on 30 September 2024. Over the past year, it has increased by +$5.89 billion (+22.61%). NVS quarterly long term liabilities is now -26.19% below its all-time high of $43.29 billion, reached on 30 September 2020.NVS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVS Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.8% | +22.6% |
| 3 y3 years | -29.6% | -7.1% |
| 5 y5 years | -28.1% | -9.1% |
NVS Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -29.6% | at low | -7.1% | +26.3% |
| 5 y | 5 years | -29.6% | at low | -26.2% | +26.3% |
| alltime | all time | -29.6% | +349.9% | -26.2% | +452.0% |
Novartis AG Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $31.95 B(+14.1%) |
| June 2024 | - | $27.99 B(+10.7%) |
| Mar 2024 | - | $25.29 B(-5.7%) |
| Dec 2023 | $26.80 B(-8.7%) | $26.80 B(+2.9%) |
| Sept 2023 | - | $26.06 B(-4.0%) |
| June 2023 | - | $27.14 B(-8.2%) |
| Mar 2023 | - | $29.55 B(+0.6%) |
| Dec 2022 | $29.37 B(-13.0%) | $29.37 B(-0.1%) |
| Sept 2022 | - | $29.41 B(-8.8%) |
| June 2022 | - | $32.26 B(-4.3%) |
| Mar 2022 | - | $33.71 B(-0.2%) |
| Dec 2021 | $33.77 B(-11.3%) | $33.77 B(-1.8%) |
| Sept 2021 | - | $34.39 B(-14.6%) |
| June 2021 | - | $40.25 B(-1.8%) |
| Mar 2021 | - | $41.00 B(+7.8%) |
| Dec 2020 | $38.05 B(+10.1%) | $38.05 B(-12.1%) |
| Sept 2020 | - | $43.29 B(+6.9%) |
| June 2020 | - | $40.50 B(-0.8%) |
| Mar 2020 | - | $40.83 B(+18.1%) |
| Dec 2019 | $34.55 B(-7.3%) | $34.55 B(-1.7%) |
| Sept 2019 | - | $35.15 B(+1.4%) |
| June 2019 | - | $34.68 B(+0.5%) |
| Mar 2019 | - | $34.51 B(-7.4%) |
| Dec 2018 | $37.26 B(+5.1%) | $37.26 B(+1.7%) |
| Sept 2018 | - | $36.65 B(-1.5%) |
| June 2018 | - | $37.21 B(+3.1%) |
| Mar 2018 | - | $36.09 B(+1.8%) |
| Dec 2017 | $35.45 B(+7.3%) | $35.45 B(-4.8%) |
| Sept 2017 | - | $37.22 B(-1.1%) |
| June 2017 | - | $37.63 B(-1.0%) |
| Mar 2017 | - | $38.01 B(+15.1%) |
| Dec 2016 | $33.02 B(+7.5%) | $33.02 B(-3.8%) |
| Sept 2016 | - | $34.34 B(+5.2%) |
| June 2016 | - | $32.63 B(-0.3%) |
| Mar 2016 | - | $32.74 B(+6.6%) |
| Dec 2015 | $30.73 B(+11.4%) | $30.73 B(+9.8%) |
| Sept 2015 | - | $27.98 B(+2.9%) |
| June 2015 | - | $27.19 B(-7.6%) |
| Mar 2015 | - | $29.44 B(+6.8%) |
| Dec 2014 | $27.57 B(+8.5%) | $27.57 B(+0.9%) |
| Sept 2014 | - | $27.34 B(-1.3%) |
| June 2014 | - | $27.70 B(-8.4%) |
| Mar 2014 | - | $30.24 B(+19.0%) |
| Dec 2013 | $25.41 B(-17.7%) | $25.41 B(-4.5%) |
| Sept 2013 | - | $26.60 B(-1.7%) |
| June 2013 | - | $27.06 B(-1.6%) |
| Mar 2013 | - | $27.49 B(-11.0%) |
| Dec 2012 | $30.88 B | $30.88 B(-4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $32.16 B(+9.6%) |
| June 2012 | - | $29.33 B(+1.7%) |
| Mar 2012 | - | $28.85 B(+1.6%) |
| Dec 2011 | $28.41 B(-1.7%) | $28.41 B(-3.4%) |
| Sept 2011 | - | $29.41 B(+0.4%) |
| June 2011 | - | $29.29 B(-1.3%) |
| Mar 2011 | - | $29.66 B(+2.7%) |
| Dec 2010 | $28.89 B(+55.6%) | $28.89 B(-6.1%) |
| Sept 2010 | - | $30.75 B(+32.1%) |
| June 2010 | - | $23.28 B(+0.6%) |
| Mar 2010 | - | $23.15 B(+24.6%) |
| Dec 2009 | $18.57 B(+63.5%) | $18.57 B(-4.6%) |
| Sept 2009 | - | $19.47 B(+5.7%) |
| June 2009 | - | $18.43 B(+10.0%) |
| Mar 2009 | - | $16.75 B(+47.5%) |
| Dec 2008 | $11.36 B(+20.6%) | $11.36 B(+0.3%) |
| Sept 2008 | - | $11.33 B(-6.5%) |
| June 2008 | - | $12.11 B(+21.2%) |
| Mar 2008 | - | $10.00 B(+6.2%) |
| Dec 2007 | $9.41 B(-10.2%) | $9.41 B(-5.3%) |
| Sept 2007 | - | $9.94 B(-9.4%) |
| June 2007 | - | $10.98 B(+6.9%) |
| Mar 2007 | - | $10.27 B(-2.0%) |
| Dec 2006 | $10.48 B(+13.4%) | $10.48 B(-12.4%) |
| Sept 2006 | - | $11.96 B(-0.4%) |
| June 2006 | - | $12.01 B(+26.3%) |
| Mar 2006 | - | $9.50 B(+2.9%) |
| Dec 2005 | $9.24 B(-0.9%) | $9.24 B(-11.8%) |
| Sept 2005 | - | $10.47 B(+4.7%) |
| June 2005 | - | $10.01 B(+12.9%) |
| Mar 2005 | - | $8.86 B(-5.0%) |
| Dec 2004 | $9.32 B(-1.6%) | $9.32 B(-1.1%) |
| Sept 2004 | - | $9.43 B(+0.3%) |
| June 2004 | - | $9.40 B(-1.3%) |
| Mar 2004 | - | $9.52 B(+0.5%) |
| Dec 2003 | $9.48 B(+12.6%) | $9.48 B(-0.7%) |
| Sept 2003 | - | $9.54 B(+1.5%) |
| June 2003 | - | $9.40 B(+3.2%) |
| Mar 2003 | - | $9.11 B(+8.2%) |
| Dec 2002 | $8.42 B(+36.7%) | $8.42 B(+20.8%) |
| Sept 2002 | - | $6.97 B(-0.8%) |
| June 2002 | - | $7.02 B(+14.0%) |
| Dec 2001 | $6.16 B(+3.4%) | $6.16 B(+6.4%) |
| June 2001 | - | $5.79 B(-2.9%) |
| Dec 2000 | $5.96 B(-11.1%) | $5.96 B(-10.3%) |
| June 2000 | - | $6.64 B |
| Dec 1999 | $6.70 B(-4.4%) | - |
| Dec 1998 | $7.01 B | - |
FAQ
- What is Novartis AG annual total long term liabilities?
- What is the all time high annual total long term liabilities for Novartis AG?
- What is Novartis AG annual total long term liabilities year-on-year change?
- What is Novartis AG quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Novartis AG?
- What is Novartis AG quarterly long term liabilities year-on-year change?
What is Novartis AG annual total long term liabilities?
The current annual total long term liabilities of NVS is $26.80 B
What is the all time high annual total long term liabilities for Novartis AG?
Novartis AG all-time high annual total long term liabilities is $38.05 B
What is Novartis AG annual total long term liabilities year-on-year change?
Over the past year, NVS annual total long term liabilities has changed by -$2.57 B (-8.75%)
What is Novartis AG quarterly total long term liabilities?
The current quarterly long term liabilities of NVS is $31.95 B
What is the all time high quarterly long term liabilities for Novartis AG?
Novartis AG all-time high quarterly total long term liabilities is $43.29 B
What is Novartis AG quarterly long term liabilities year-on-year change?
Over the past year, NVS quarterly total long term liabilities has changed by +$5.89 B (+22.61%)